MBD2 and pulmonary fibrosis: The methyl-CpG-binding domain 2 (MBD2) facilitates pulmonary fibrosis by orchestrating fibroblast-to-myofibroblast differentiation, and strategies aimed at silencing MBD2 can be potential therapeutic approaches for the prevention and treatment of pulmonary fibrosis (Wang et al., 2022).